Sign-up for Advaxis Submits Investigational New Drug Application for Phase 1/2 Study of ADXS-HPV and MedImmune's MEDI4736 for the Treatment of HPV-Associated Cervical and Head & Neck Cancer investment picks
Zep Inc. (NYSE: ZEP), a leading consumable chemical packaged goods
company that manufactures a wide variety of high-performance maintenance
and cleaning chemicals, today reported financial results for the
three-month and twelve-month periods ended August 31, 2014.
The overwhelming majority of employees believe telecommuting is good for
both themselves and their company, but most organizations are not
budgeting appropriately for telecommuters, according to a recent survey
of procurement officers by Staples
Advantage , the business-to-business division of Staples, Inc.
Two-thirds of those who responded say they do not take telecommuters
into account when planning their organization’s purchasing budget.
Pharmaceuticals, Inc. (NASDAQ: TTPH) , a clinical-stage
biopharmaceutical company whose lead product candidate, eravacycline, is
being developed as a broad-spectrum intravenous and oral antibiotic
designed to be effective against dangerous, drug-resistant bacteria
(including multidrug-resistant (MDR) Gram-negative pathogens), today
announced its participation in two upcoming investor conferences:
A live audio webcast of the Stifel presentation will be available on the
Company's website at http://ir.tphase.com/events.cfm .
Starwood Waypoint Residential Trust (NYSE:SWAY) (the “Company”), a
leading single-family rental real estate investment trust (“REIT”),
today announced its operating and financial results for the third
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.